| Ronald F Taylor, MD | |
|
2863 Highway 45 Byp, Jackson, TN 38305-3618 | |
| (731) 422-0213 | |
| (731) 422-0410 |
| Full Name | Ronald F Taylor |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 42 Years |
| Location | 2863 Highway 45 Byp, Jackson, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275501561 | NPI | - | NPPES |
| 3016833 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD14972 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jackson-madison County General Hospital | Jackson, TN | Hospital |
| Dyersburg Regional Medical Center | Dyersburg, TN | Hospital |
| Camden General Hospital | Camden, TN | Hospital |
| Milan General Hospital | Milan, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jackson Clinic Pa | 2668376872 | 176 |
News Archive
Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007.
Stress during the first trimester of pregnancy alters the population of microbes living in a mother's vagina. Those changes are passed on to newborns during birth and are associated with differences in their gut microbiome as well as their brain development, according to a new study by University of Pennsylvania researchers.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
As members of the community gathered at the Markham Civic Centre today to learn more about Red Cross response to the floods in Pakistan, The Sprott Foundation came forward with a donation of $500,000 to support their efforts.
› Verified 5 days ago
| Entity Name | Jackson Madison County General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396770442 PECOS PAC ID: 3678481975 Enrollment ID: O20031206000034 |
News Archive
Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007.
Stress during the first trimester of pregnancy alters the population of microbes living in a mother's vagina. Those changes are passed on to newborns during birth and are associated with differences in their gut microbiome as well as their brain development, according to a new study by University of Pennsylvania researchers.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
As members of the community gathered at the Markham Civic Centre today to learn more about Red Cross response to the floods in Pakistan, The Sprott Foundation came forward with a donation of $500,000 to support their efforts.
› Verified 5 days ago
| Entity Name | Jackson Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285629386 PECOS PAC ID: 2668376872 Enrollment ID: O20040318000962 |
News Archive
Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007.
Stress during the first trimester of pregnancy alters the population of microbes living in a mother's vagina. Those changes are passed on to newborns during birth and are associated with differences in their gut microbiome as well as their brain development, according to a new study by University of Pennsylvania researchers.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
As members of the community gathered at the Markham Civic Centre today to learn more about Red Cross response to the floods in Pakistan, The Sprott Foundation came forward with a donation of $500,000 to support their efforts.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald F Taylor, MD Po Box 400, Jackson, TN 38302-0400 Ph: (731) 425-5752 | Ronald F Taylor, MD 2863 Highway 45 Byp, Jackson, TN 38305-3618 Ph: (731) 422-0213 |
News Archive
Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007.
Stress during the first trimester of pregnancy alters the population of microbes living in a mother's vagina. Those changes are passed on to newborns during birth and are associated with differences in their gut microbiome as well as their brain development, according to a new study by University of Pennsylvania researchers.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
As members of the community gathered at the Markham Civic Centre today to learn more about Red Cross response to the floods in Pakistan, The Sprott Foundation came forward with a donation of $500,000 to support their efforts.
› Verified 5 days ago
John Baker, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 587 Skyline Dr, Jackson, TN 38301 Phone: 731-421-6510 Fax: 731-421-6500 | |
Dr. Susan Alex, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 221 Sterling Farms Dr., Jackson, TN 38305 Phone: 731-668-4337 Fax: 731-661-0124 | |
Dr. Kelsey B Dexter, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2863 Highway 45 Byp, Jackson, TN 38305 Phone: 731-422-0213 Fax: 731-660-8336 | |
Kpienoba Manan Hien, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 620 Skyline Dr, Jackson, TN 38301 Phone: 731-541-5000 | |
Lucas Carver, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 620 Skyline Dr, Jackson, TN 38301 Phone: 731-541-5000 | |
Dr. Clyde E Smith, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 27 Medical Center Dr, Jackson, TN 38301 Phone: 731-424-1001 | |
Brittain Douglas Little, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 27 Medical Center Dr, Jackson, TN 38301 Phone: 731-424-1001 Fax: 731-426-0388 |